Gossamer Bio, Inc. GOSS Q1 2025 earnings
Reported May 15, 2025 · After market close
Revenue estimate$3.9M
EPS estimate-$0.18
Next report
Aug 4, 2026 (In 3 weeks)Revenue estimate$4.3M
EPS estimate-$0.08
Versus estimates
Revenue
Diluted EPS
Ask the moment Gossamer Bio, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Gossamer Bio, Inc. report Q1 2025 earnings?
- Gossamer Bio, Inc. (GOSS) reported Q1 2025 earnings on May 15, 2025 after market close.
- What were Gossamer Bio, Inc.'s Q1 2025 revenue and EPS?
- Gossamer Bio, Inc. reported revenue of $9.9M and diluted EPS of $-0.16 for Q1 2025.
- Did Gossamer Bio, Inc. beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $3.9M by $5.9M. EPS beat the consensus estimate of $-0.18 by $0.02.
- How did Gossamer Bio, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 15.8% from $-0.19.
- Where can I find Gossamer Bio, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001728117-25-000036) directly on SEC EDGAR. The filing index links above go to sec.gov.